{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:52:39Z","timestamp":1792788759198,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.ppat.1013052","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000}}],"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFC2306600"],"award-info":[{"award-number":["2023YFC2306600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372241, 82172261"],"award-info":[{"award-number":["82372241, 82172261"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Wuhan","award":["2024040701010031"],"award-info":[{"award-number":["2024040701010031"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["2042022dx0003"],"award-info":[{"award-number":["2042022dx0003"]}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>\n                    The development of effective and broad-spectrum antiviral therapies remains an unmet need. Current virus-targeted antiviral strategies are often limited by narrow spectrum of activity and the rapid emergence of resistance. As a result, there is increasing interest in alternative approaches that target host cell factors critical for viral replication. One promising strategy is the targeting of deubiquitinases (DUBs), enzymes that regulate key host and viral proteins involved in viral reactivation and replication. In this study, we explore the potential of targeting a DUB complex for antiviral therapy based on our previous study. Our previous work revealed that the OTUD4-USP7 DUB complex plays a crucial role in KSHV lytic reactivation. Here, we developed a peptide, p8, which effectively disrupts the interaction between OTUD4 and USP7, leading to decreased abundance of the key viral transcription factor, RTA, and suppression of murine herpesvirus replication\n                    <jats:italic>in vivo<\/jats:italic>\n                    . These findings underscore the OTUD4-USP7 DUB complex as a promising host-targeting antiviral therapeutic target for the treatment of KSHV-associated malignancies. Moreover, our study highlights the potential of DUB-targeting therapies as a novel and effective strategy for the development of broad-spectrum antiviral agents.\n                  <\/jats:p>","DOI":"10.1371\/journal.ppat.1013052","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T13:31:56Z","timestamp":1744291916000},"page":"e1013052","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Disrupting the OTUD4-USP7 deubiquitinase complex to suppress herpesvirus replication: a novel antiviral strategy"],"prefix":"10.1371","volume":"21","author":[{"given":"Shaowei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuchu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinghui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3812-3850","authenticated-orcid":true,"given":"Junjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"issue":"2","key":"ppat.1013052.ref001","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tips.2013.11.006","article-title":"Current progress in antiviral strategies","volume":"35","author":"Z Lou","year":"2014","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"ppat.1013052.ref002","first-page":"585","article-title":"Accelerating antiviral drug discovery: lessons from COVID-19 development programmes, and may continue to be involved in future programmes. These programmes may lead to the generation of intellectual property for their respective employers, and may directly or indirectly contribute to past, present or future revenue of their respective employers. M.D.H. is an employee of NCATS, A.K. is an employee of Pardes Biosciences, L.A.P. is an employee of Vir Biotechnology, K.S.S. is an employee of Takeda California, Inc., U.S. is an employee of Gilead Sciences, J.A.T. is an employee of Novartis Institutes for Biomedical Research, A.v.D. is an employee of Oxford University, and consults for PostEra, Inc. A.A.L. is an employee of Cambridge University and CSO for PostEra, Inc","volume":"22","author":"A von Delft","year":"2023","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"ppat.1013052.ref003","doi-asserted-by":"crossref","first-page":"e170236","DOI":"10.1172\/JCI170236","article-title":"Preparing for the next viral threat with broad-spectrum antivirals","volume":"133","author":"M Karim","year":"2023","journal-title":"J Clin Invest"},{"issue":"3","key":"ppat.1013052.ref004","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00168-19","article-title":"Host-Directed Antiviral Therapy","volume":"33","author":"N Kumar","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"ppat.1013052.ref005","volume-title":"Fields Virology, 6th Edition","author":"DM Knipe","year":"2003"},{"issue":"3","key":"ppat.1013052.ref006","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbadis.2007.12.005","article-title":"Viruses associated with human cancer","volume":"1782","author":"ME McLaughlin-Drubin","year":"2008","journal-title":"Biochim Biophys Acta"},{"issue":"1732","key":"ppat.1013052.ref007","doi-asserted-by":"crossref","first-page":"20160264","DOI":"10.1098\/rstb.2016.0264","article-title":"Human oncogenic viruses: nature and discovery","volume":"372","author":"Y Chang","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"5192","key":"ppat.1013052.ref008","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi\u2019s sarcoma","volume":"266","author":"Y Chang","year":"1994","journal-title":"Science"},{"issue":"4","key":"ppat.1013052.ref009","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman\u2019s disease [see comments]","volume":"86","author":"J Soulier","year":"1995","journal-title":"Blood"},{"issue":"18","key":"ppat.1013052.ref010","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas","volume":"332","author":"E Cesarman","year":"1995","journal-title":"N Engl J Med"},{"issue":"6","key":"ppat.1013052.ref011","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/cid\/civ996","article-title":"Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS)","volume":"62","author":"MN Polizzotto","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"9","key":"ppat.1013052.ref012","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1172\/JCI84418","article-title":"Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy","volume":"126","author":"DP Dittmer","year":"2016","journal-title":"J Clin Invest"},{"issue":"3","key":"ppat.1013052.ref013","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/654798","article-title":"An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease","volume":"51","author":"TS Uldrick","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ppat.1013052.ref014","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12250-019-00114-3","article-title":"Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis","volume":"34","author":"L Yan","year":"2019","journal-title":"Virol Sin"},{"issue":"9","key":"ppat.1013052.ref015","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3390\/v12091034","article-title":"Regulation of KSHV Latency and Lytic Reactivation","volume":"12","author":"G Broussard","year":"2020","journal-title":"Viruses"},{"key":"ppat.1013052.ref016","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3389\/fmicb.2017.00613","article-title":"Reactivation and Lytic Replication of Kaposi\u2019s Sarcoma-Associated Herpesvirus: An Update","volume":"8","author":"KK Aneja","year":"2017","journal-title":"Front Microbiol"},{"key":"ppat.1013052.ref017","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coviro.2018.08.014","article-title":"Contribution of the KSHV and EBV lytic cycles to tumourigenesis","volume":"32","author":"O Manners","year":"2018","journal-title":"Curr Opin Virol"},{"issue":"1","key":"ppat.1013052.ref018","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1172\/JCI200417803","article-title":"Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis","volume":"113","author":"A Grundhoff","year":"2004","journal-title":"J Clin Invest"},{"key":"ppat.1013052.ref019","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bcp.2016.03.021","article-title":"Hijacking GPCRs by viral pathogens and tumor","volume":"114","author":"J Zhang","year":"2016","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"ppat.1013052.ref020","doi-asserted-by":"crossref","first-page":"e1004768","DOI":"10.1371\/journal.ppat.1004768","article-title":"Herpesviral G protein-coupled receptors activate NFAT to induce tumor formation via inhibiting the SERCA calcium ATPase","volume":"11","author":"J Zhang","year":"2015","journal-title":"PLoS Pathog"},{"key":"ppat.1013052.ref021","doi-asserted-by":"crossref","first-page":"605258","DOI":"10.3389\/fcimb.2021.605258","article-title":"The Role of Lytic Infection for Lymphomagenesis of Human \u03b3-Herpesviruses","volume":"11","author":"C M\u00fcnz","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"ppat.1013052.ref022","doi-asserted-by":"crossref","first-page":"e1004154","DOI":"10.1371\/journal.ppat.1004154","article-title":"Molecular and cellular mechanisms of KSHV oncogenesis of Kaposi\u2019s sarcoma associated with HIV\/AIDS","volume":"10","author":"LE Cavallin","year":"2014","journal-title":"PLoS Pathog"},{"issue":"1","key":"ppat.1013052.ref023","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1535-6108(02)00237-4","article-title":"Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi\u2019s sarcomagenesis and can promote the tumorigenic potential of viral latent genes","volume":"3","author":"S Montaner","year":"2003","journal-title":"Cancer Cell"},{"issue":"14","key":"ppat.1013052.ref024","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199904083401402","article-title":"Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group","volume":"340","author":"DF Martin","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"ppat.1013052.ref025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/588820","article-title":"Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial","volume":"198","author":"C Casper","year":"2008","journal-title":"J Infect Dis"},{"key":"ppat.1013052.ref026","first-page":"289","article-title":"The use of antiviral drugs in the prevention and treatment of Kaposi sarcoma, multicentric Castleman disease and primary effusion lymphoma","volume":"312","author":"C Casper","year":"2007","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"ppat.1013052.ref027","doi-asserted-by":"crossref","first-page":"e1011943","DOI":"10.1371\/journal.ppat.1011943","article-title":"Non-canonical regulation of the reactivation of an oncogenic herpesvirus by the OTUD4-USP7 deubiquitinases","volume":"20","author":"S Wang","year":"2024","journal-title":"PLoS Pathog"},{"issue":"22","key":"ppat.1013052.ref028","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/j.jmb.2017.05.028","article-title":"Regulation of USP7: A High Incidence of E3 Complexes","volume":"429","author":"RQ Kim","year":"2017","journal-title":"J Mol Biol"},{"issue":"25","key":"ppat.1013052.ref029","doi-asserted-by":"crossref","first-page":"16010","DOI":"10.1074\/jbc.272.25.16010","article-title":"A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus","volume":"272","author":"E Viv\u00e8s","year":"1997","journal-title":"J Biol Chem"},{"issue":"8016","key":"ppat.1013052.ref030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"J Abramson","year":"2024","journal-title":"Nature"},{"issue":"2","key":"ppat.1013052.ref031","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1371\/journal.pbio.0040027","article-title":"Structural basis of competitive recognition of p53 and MDM2 by HAUSP\/USP7: implications for the regulation of the p53-MDM2 pathway","volume":"4","author":"M Hu","year":"2006","journal-title":"PLoS Biol"},{"issue":"1","key":"ppat.1013052.ref032","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.molcel.2005.02.029","article-title":"Structure of the p53 binding domain of HAUSP\/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization","volume":"18","author":"V Saridakis","year":"2005","journal-title":"Mol Cell"},{"issue":"3","key":"ppat.1013052.ref033","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nsmb1067","article-title":"Molecular recognition of p53 and MDM2 by USP7\/HAUSP","volume":"13","author":"Y Sheng","year":"2006","journal-title":"Nat Struct Mol Biol"},{"issue":"12","key":"ppat.1013052.ref034","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/nsmb.2142","article-title":"Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein","volume":"18","author":"H-R Lee","year":"2011","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"ppat.1013052.ref035","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/MCB.00639-13","article-title":"A role for USP7 in DNA replication","volume":"34","author":"M Jagannathan","year":"2014","journal-title":"Mol Cell Biol"},{"issue":"5","key":"ppat.1013052.ref036","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jmb.2010.08.017","article-title":"Further insight into substrate recognition by USP7: structural and biochemical analysis of the HdmX and Hdm2 interactions with USP7","volume":"402","author":"F Sarkari","year":"2010","journal-title":"J Mol Biol"},{"key":"ppat.1013052.ref037","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41392-018-0012-y","article-title":"Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases","volume":"3","author":"S Bhattacharya","year":"2018","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"ppat.1013052.ref038","doi-asserted-by":"crossref","first-page":"e0054923","DOI":"10.1128\/mbio.00549-23","article-title":"Genome-Wide CRISPR-Cas9 Screen Identifies SMCHD1 as a Restriction Factor for Herpesviruses","volume":"14","author":"X Tian","year":"2023","journal-title":"mBio"},{"issue":"18","key":"ppat.1013052.ref039","doi-asserted-by":"crossref","first-page":"9708","DOI":"10.1128\/JVI.01019-12","article-title":"Construction and manipulation of a new Kaposi\u2019s sarcoma-associated herpesvirus bacterial artificial chromosome clone","volume":"86","author":"KF Brulois","year":"2012","journal-title":"J Virol"},{"issue":"6","key":"ppat.1013052.ref040","doi-asserted-by":"crossref","first-page":"e1005001","DOI":"10.1371\/journal.ppat.1005001","article-title":"Recombinant Murine Gamma Herpesvirus 68 Carrying KSHV G Protein-Coupled Receptor Induces Angiogenic Lesions in Mice","volume":"11","author":"J Zhang","year":"2015","journal-title":"PLoS Pathog"},{"issue":"11","key":"ppat.1013052.ref041","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1128\/JVI.77.11.6474-6481.2003","article-title":"Host range of Kaposi\u2019s sarcoma-associated herpesvirus in cultured cells","volume":"77","author":"JT Bechtel","year":"2003","journal-title":"J Virol"},{"issue":"5","key":"ppat.1013052.ref042","article-title":"The complete Kaposi sarcoma-associated herpesvirus genome induces early-onset, metastatic angiosarcoma in transgenic mice","volume":"32","author":"S-H Sin","year":"2024","journal-title":"Cell Host Microbe"},{"issue":"7","key":"ppat.1013052.ref043","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0966-842X(98)01306-7","article-title":"Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis","volume":"6","author":"JP Simas","year":"1998","journal-title":"Trends Microbiol"},{"issue":"21","key":"ppat.1013052.ref044","doi-asserted-by":"crossref","first-page":"9765","DOI":"10.1073\/pnas.91.21.9765","article-title":"Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics","volume":"91","author":"G Guichard","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"ppat.1013052.ref045","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/nm911","article-title":"A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia","volume":"9","author":"T Borsello","year":"2003","journal-title":"Nat Med"},{"issue":"1","key":"ppat.1013052.ref046","article-title":"Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging","volume":"169","author":"MP Baar","year":"2017","journal-title":"Cell"},{"issue":"10","key":"ppat.1013052.ref047","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2021.08.027","article-title":"Inhibition of viral suppressor of RNAi proteins by designer peptides protects from enteroviral infection in vivo","volume":"54","author":"Y Fang","year":"2021","journal-title":"Immunity"},{"issue":"2","key":"ppat.1013052.ref048","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/jop.2013.0247","article-title":"Subconjunctival injection of XG-102, a JNK inhibitor peptide, in patients with intraocular inflammation: a safety and tolerability study","volume":"31","author":"T Beydoun","year":"2015","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"ppat.1013052.ref049","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.cell.2021.02.013","article-title":"Antivirals with common targets against highly pathogenic viruses","volume":"184","author":"L Lu","year":"2021","journal-title":"Cell"},{"issue":"5","key":"ppat.1013052.ref050","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.coviro.2012.09.001","article-title":"New horizons for antiviral drug discovery from virus-host protein interaction networks","volume":"2","author":"B de Chassey","year":"2012","journal-title":"Curr Opin Virol"},{"key":"ppat.1013052.ref051","doi-asserted-by":"crossref","first-page":"839624","DOI":"10.3389\/fmicb.2022.839624","article-title":"The Role of Deubiquitinases in Virus Replication and Host Innate Immune Response","volume":"13","author":"Q Zhang","year":"2022","journal-title":"Front Microbiol"},{"issue":"5","key":"ppat.1013052.ref052","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1053\/j.gastro.2006.08.043","article-title":"Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection","volume":"131","author":"G Randall","year":"2006","journal-title":"Gastroenterology"},{"issue":"7","key":"ppat.1013052.ref053","doi-asserted-by":"crossref","first-page":"e1002783","DOI":"10.1371\/journal.ppat.1002783","article-title":"Antiviral activity of a small molecule deubiquitinase inhibitor occurs via induction of the unfolded protein response","volume":"8","author":"JW Perry","year":"2012","journal-title":"PLoS Pathog"},{"key":"ppat.1013052.ref054","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.3389\/fimmu.2019.03084","article-title":"KSHV: Immune Modulation and Immunotherapy","volume":"10","author":"G Broussard","year":"2020","journal-title":"Front Immunol"},{"issue":"9","key":"ppat.1013052.ref055","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.3390\/v13091797","article-title":"Recent Advances in Developing Treatments of Kaposi\u2019s Sarcoma Herpesvirus-Related Diseases","volume":"13","author":"E Naimo","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"ppat.1013052.ref056","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13027-024-00566-7","article-title":"Nelfinavir inhibition of Kaposi\u2019s sarcoma-associated herpesvirus protein expression and capsid assembly","volume":"19","author":"M Li","year":"2024","journal-title":"Infect Agent Cancer"},{"key":"ppat.1013052.ref057","doi-asserted-by":"crossref","first-page":"105990","DOI":"10.1016\/j.antiviral.2024.105990","article-title":"Discovery of a small-molecule inhibitor of KSHV lytic replication from the MMV pandemic response box","volume":"230","author":"MO Okpara","year":"2024","journal-title":"Antiviral Res"},{"key":"ppat.1013052.ref058","doi-asserted-by":"crossref","first-page":"16201","DOI":"10.1038\/nmicrobiol.2016.201","article-title":"Targeting the ATP-dependent formation of herpesvirus ribonucleoprotein particle assembly as an antiviral approach","volume":"2","author":"S Schumann","year":"2016","journal-title":"Nat Microbiol"},{"issue":"12","key":"ppat.1013052.ref059","doi-asserted-by":"crossref","first-page":"e1008156","DOI":"10.1371\/journal.ppat.1008156","article-title":"Identification of new antiviral agents against Kaposi\u2019s sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation","volume":"15","author":"J Chen","year":"2019","journal-title":"PLoS Pathog"},{"issue":"6497","key":"ppat.1013052.ref060","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"W Dai","year":"2020","journal-title":"Science"},{"issue":"3","key":"ppat.1013052.ref061","doi-asserted-by":"crossref","first-page":"100100","DOI":"10.1016\/j.cellin.2023.100100","article-title":"The deubiquitinase OTUD4 inhibits the expression of antimicrobial peptides in Paneth cells to support intestinal inflammation and bacterial infection","volume":"2","author":"K Yu","year":"2023","journal-title":"Cell Insight"},{"issue":"1","key":"ppat.1013052.ref062","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41422-018-0107-6","article-title":"Induction of OTUD4 by viral infection promotes antiviral responses through deubiquitinating and stabilizing MAVS","volume":"29","author":"T Liuyu","year":"2019","journal-title":"Cell Res"},{"issue":"12","key":"ppat.1013052.ref063","doi-asserted-by":"crossref","first-page":"e2218825120","DOI":"10.1073\/pnas.2218825120","article-title":"RNF213 modulates \u03b3-herpesvirus infection and reactivation via targeting the viral Replication and Transcription Activator","volume":"120","author":"H Tian","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"ppat.1013052.ref064","doi-asserted-by":"crossref","first-page":"e1004993","DOI":"10.1371\/journal.ppat.1004993","article-title":"Phosphoproteomic Analysis of KSHV-Infected Cells Reveals Roles of ORF45-Activated RSK during Lytic Replication","volume":"11","author":"D Avey","year":"2015","journal-title":"PLoS Pathog"},{"issue":"1","key":"ppat.1013052.ref065","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1038\/s41467-020-19941-0","article-title":"DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity","volume":"11","author":"X Sun","year":"2020","journal-title":"Nat Commun"},{"issue":"8","key":"ppat.1013052.ref066","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41556-023-01185-x","article-title":"STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2","volume":"25","author":"L Zhang","year":"2023","journal-title":"Nat Cell Biol"},{"issue":"4","key":"ppat.1013052.ref067","doi-asserted-by":"crossref","first-page":"e1012141","DOI":"10.1371\/journal.ppat.1012141","article-title":"Palmitoylation of KSHV pORF55 is required for Golgi localization and efficient progeny virion production","volume":"20","author":"Y Zhou","year":"2024","journal-title":"PLoS Pathog"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1013052","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1013052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:50:03Z","timestamp":1746193803000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1013052"}},"subtitle":[],"editor":[{"given":"Italo","family":"Tempera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":67,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1013052","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]}}}